InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,599.60
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.44
(
-0.05%
)
Bitcoin
63,112.22
(
-0.09%
)
Post# of 251732
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 253
Posts 17908
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: DewDiligence post# 209420

Sunday, 02/26/2017 6:05:28 PM

Sunday, February 26, 2017 6:05:28 PM

Post# of 251732
Amarin's Phase 3 Reduce-It study of Vascepa/statin was continued, per 2016 DSMB/IDMC recommendation at planned 1st interim. 2nd interim look planned in 2017, including result data for PI and at least 30 secondary indications. Enrollment > 8000.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up